Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys and Robatrol for 24 vs 48 weeks in Taiwanese HCV Genotype 1
NCT00495131Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2006
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C virus infection, sponsored by National Taiwan University Hospital. Started Jun 2006; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00495131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495131.